Ignite Creation Date:
2024-05-06 @ 5:15 PM
Last Modification Date:
2024-10-26 @ 2:25 PM
Study NCT ID:
NCT05245500
Status:
RECRUITING
Last Update Posted:
2024-06-21
First Post:
2022-02-01
Brief Title:
Phase 12 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Sponsor:
Mirati Therapeutics Inc
Organization:
Mirati Therapeutics Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-06-02
Start Date Type:
ACTUAL
Primary Completion Date:
2026-04-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-04-30
Completion Date Type:
ESTIMATED
First Submit Date:
2022-02-01
First Submit QC Date:
February 14 2022
Study First Post Date:
2022-02-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-16
Last Update Post Date:
2024-06-21
Last Update Post Date Type:
ACTUAL